Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

BIT:1ELX - Euronext Milan - US5184391044 - Common Stock - Currency: EUR

65.8  +3 (+4.78%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1ELX. 1ELX was compared to 14 industry peers in the Personal Care Products industry. Both the profitability and financial health of 1ELX have multiple concerns. 1ELX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1ELX was profitable.
1ELX had a positive operating cash flow in the past year.
Each year in the past 5 years 1ELX has been profitable.
Each year in the past 5 years 1ELX had a positive operating cash flow.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

1ELX has a worse Return On Assets (-3.54%) than 92.86% of its industry peers.
1ELX has a worse Return On Equity (-16.79%) than 92.86% of its industry peers.
1ELX has a worse Return On Invested Capital (6.30%) than 64.29% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ELX is below the industry average of 11.38%.
Industry RankSector Rank
ROA -3.54%
ROE -16.79%
ROIC 6.3%
ROA(3y)5.84%
ROA(5y)6.89%
ROE(3y)22.7%
ROE(5y)26.57%
ROIC(3y)9.14%
ROIC(5y)9.86%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

In the last couple of years the Profit Margin of 1ELX has declined.
Looking at the Operating Margin, with a value of 9.76%, 1ELX is doing worse than 64.29% of the companies in the same industry.
1ELX's Operating Margin has declined in the last couple of years.
1ELX's Gross Margin of 73.09% is fine compared to the rest of the industry. 1ELX outperforms 78.57% of its industry peers.
1ELX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.76%
PM (TTM) N/A
GM 73.09%
OM growth 3Y-18.75%
OM growth 5Y-10.71%
PM growth 3Y-47.93%
PM growth 5Y-26.95%
GM growth 3Y-2.09%
GM growth 5Y-1.48%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

1ELX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for 1ELX has been increased compared to 1 year ago.
1ELX has less shares outstanding than it did 5 years ago.
1ELX has a worse debt/assets ratio than last year.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 2.95 indicates that 1ELX is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.95, 1ELX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
1ELX has a debt to FCF ratio of 6.36. This is a slightly negative value and a sign of low solvency as 1ELX would need 6.36 years to pay back of all of its debts.
1ELX has a worse Debt to FCF ratio (6.36) than 78.57% of its industry peers.
A Debt/Equity ratio of 1.75 is on the high side and indicates that 1ELX has dependencies on debt financing.
1ELX has a worse Debt to Equity ratio (1.75) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF 6.36
Altman-Z 2.95
ROIC/WACC0.83
WACC7.55%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.37 indicates that 1ELX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.37, 1ELX is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
1ELX has a Quick Ratio of 1.37. This is a bad value and indicates that 1ELX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.97, 1ELX is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.97
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

1ELX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.90%, which is quite impressive.
The earnings per share for 1ELX have been decreasing by -13.41% on average. This is quite bad
The Revenue has decreased by -0.02% in the past year.
1ELX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.98% yearly.
EPS 1Y (TTM)54.9%
EPS 3Y-26.13%
EPS 5Y-13.41%
EPS Q2Q%-29.55%
Revenue 1Y (TTM)-0.02%
Revenue growth 3Y-1.26%
Revenue growth 5Y0.98%
Sales Q2Q%-6.43%

3.2 Future

1ELX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.26% yearly.
The Revenue is expected to grow by 3.84% on average over the next years.
EPS Next Y-44.82%
EPS Next 2Y-3.32%
EPS Next 3Y8.07%
EPS Next 5Y15.26%
Revenue Next Year-5.44%
Revenue Next 2Y-1.08%
Revenue Next 3Y0.92%
Revenue Next 5Y3.84%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 29.12, 1ELX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of 1ELX indicates a slightly more expensive valuation: 1ELX is more expensive than 71.43% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.53, 1ELX is valued at the same level.
1ELX is valuated quite expensively with a Price/Forward Earnings ratio of 28.33.
Based on the Price/Forward Earnings ratio, 1ELX is valued expensively inside the industry as 85.71% of the companies are valued cheaper.
When comparing the Price/Forward Earnings ratio of 1ELX to the average of the S&P500 Index (22.65), we can say 1ELX is valued slightly more expensively.
Industry RankSector Rank
PE 29.12
Fwd PE 28.33
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1ELX.
1ELX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 21.63
EV/EBITDA 12.74
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.32%
EPS Next 3Y8.07%

4

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 2.01%.
Compared to an average industry Dividend Yield of 2.37, 1ELX has a dividend in line with its industry peers.
1ELX's Dividend Yield is comparable with the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

The dividend of 1ELX is nicely growing with an annual growth rate of 9.59%!
Dividend Growth(5Y)9.59%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1ELX are negative and hence is the payout ratio. 1ELX will probably not be able to sustain this dividend level.
The dividend of 1ELX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-119.86%
EPS Next 2Y-3.32%
EPS Next 3Y8.07%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (2/17/2025, 7:00:00 PM)

65.8

+3 (+4.78%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-04 2025-02-04/bmo
Earnings (Next)05-01 2025-05-01/amc
Inst Owners93.04%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap23.67B
Analysts66.67
Price Target78.41 (19.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Yearly Dividend2.64
Dividend Growth(5Y)9.59%
DP-119.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.81%
Min EPS beat(2)43.76%
Max EPS beat(2)87.87%
EPS beat(4)4
Avg EPS beat(4)89.87%
Min EPS beat(4)43.76%
Max EPS beat(4)133.75%
EPS beat(8)7
Avg EPS beat(8)106.42%
EPS beat(12)11
Avg EPS beat(12)75.32%
EPS beat(16)15
Avg EPS beat(16)61.99%
Revenue beat(2)0
Avg Revenue beat(2)-2.62%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)-2.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.22%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)-1.43%
Revenue beat(8)1
Avg Revenue beat(8)-1.67%
Revenue beat(12)2
Avg Revenue beat(12)-1.86%
Revenue beat(16)4
Avg Revenue beat(16)-1.7%
PT rev (1m)7.68%
PT rev (3m)-21.06%
EPS NQ rev (1m)-51.17%
EPS NQ rev (3m)-75.77%
EPS NY rev (1m)-11.37%
EPS NY rev (3m)-11.92%
Revenue NQ rev (1m)-5.76%
Revenue NQ rev (3m)-15.64%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 29.12
Fwd PE 28.33
P/S 1.63
P/FCF 21.63
P/OCF 13.69
P/B 5.94
P/tB N/A
EV/EBITDA 12.74
EPS(TTM)2.26
EY3.43%
EPS(NY)2.32
Fwd EY3.53%
FCF(TTM)3.04
FCFY4.62%
OCF(TTM)4.81
OCFY7.31%
SpS40.31
BVpS11.07
TBVpS-5.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.54%
ROE -16.79%
ROCE 10.06%
ROIC 6.3%
ROICexc 7.64%
ROICexgc 15.69%
OM 9.76%
PM (TTM) N/A
GM 73.09%
FCFM 7.54%
ROA(3y)5.84%
ROA(5y)6.89%
ROE(3y)22.7%
ROE(5y)26.57%
ROIC(3y)9.14%
ROIC(5y)9.86%
ROICexc(3y)12.1%
ROICexc(5y)13.99%
ROICexgc(3y)27.91%
ROICexgc(5y)31.23%
ROCE(3y)14.59%
ROCE(5y)15.74%
ROICexcg growth 3Y-21.07%
ROICexcg growth 5Y-22.32%
ROICexc growth 3Y-21.66%
ROICexc growth 5Y-23.4%
OM growth 3Y-18.75%
OM growth 5Y-10.71%
PM growth 3Y-47.93%
PM growth 5Y-26.95%
GM growth 3Y-2.09%
GM growth 5Y-1.48%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF 6.36
Debt/EBITDA 3.15
Cap/Depr 79.93%
Cap/Sales 4.38%
Interest Coverage 4.23
Cash Conversion 78.25%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.97
Altman-Z 2.95
F-Score6
WACC7.55%
ROIC/WACC0.83
Cap/Depr(3y)232.17%
Cap/Depr(5y)179.27%
Cap/Sales(3y)10.8%
Cap/Sales(5y)8.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.9%
EPS 3Y-26.13%
EPS 5Y-13.41%
EPS Q2Q%-29.55%
EPS Next Y-44.82%
EPS Next 2Y-3.32%
EPS Next 3Y8.07%
EPS Next 5Y15.26%
Revenue 1Y (TTM)-0.02%
Revenue growth 3Y-1.26%
Revenue growth 5Y0.98%
Sales Q2Q%-6.43%
Revenue Next Year-5.44%
Revenue Next 2Y-1.08%
Revenue Next 3Y0.92%
Revenue Next 5Y3.84%
EBIT growth 1Y41.99%
EBIT growth 3Y-19.77%
EBIT growth 5Y-9.83%
EBIT Next Year31.76%
EBIT Next 3Y23.39%
EBIT Next 5Y19.51%
FCF growth 1Y21.16%
FCF growth 3Y-21.63%
FCF growth 5Y-4.06%
OCF growth 1Y-6.94%
OCF growth 3Y-13.38%
OCF growth 5Y-1.28%